Navigation Links
Chemotherapy is as effective before breast cancer surgery as after
Date:9/8/2011

San Francisco, CA - Whether chemotherapy is given before or after breast-conserving therapy (BCT) does not have an impact on long-term local-regional outcomes, suggesting treatment success is due more to biologic factors than chemotherapy timing, according to a study by researchers at The University of Texas MD Anderson Cancer Center.

Presented today at the 2011 Breast Cancer Symposium, the study also found that neoadjuvant chemotherapy (given before surgery), often shrinks breast cancer tumors, making them more likely to be treatable with BCT, or a lumpectomy to remove a portion of the breast followed by radiation.

"Even women who present with clinical Stage 2 or 3 breast cancer may have good results with BCT after chemotherapy and not need a mastectomy," said Elizabeth Ann Mittendorf, M.D., assistant professor in the Department of Surgical Oncology and lead author of the study. "The molecular characteristics of the tumor and other factors have an impact on treatment success, but not the order in which chemotherapy and surgery are given."

The retrospective study of almost 3,000 women treated for breast cancer at MD Anderson from 1987 to 2005 also confirmed several prior studies showing BCT offers high rates of cancer control for certain patients.

Approaches have similar outcomes

Of the patients surveyed, 78 percent had surgery before chemotherapy and 22 percent received chemotherapy first. Overall, women with more cancers that had more adverse prognostic factors tended to be treated with chemotherapy first.

Five and 10-year local-regional recurrence-free survival rates were excellent for both groups: 97 percent and 94 percent respectively for those who had surgery before chemotherapy, 93 percent and 90 percent for patients who received chemotherapy first.

Mittendorf said that if adverse features, such as stage and grade of the cancer, age of the patient and tumor hormone expression, were f
'/>"/>

Contact: Laura Sussman
lsussman@mdanderson.org
713-745-2457
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Chemotherapy can impair speech
2. UCSF study shows greater impact of chemotherapy on fertility
3. Clinical trial shows benefit to adding avastin to neoadjuvant chemotherapy in breast cancer patients
4. 17 percent of cancer nurses unintentionally exposed to chemotherapy, U-M study finds
5. Hormone reduces risk of heart failure from chemotherapy
6. A new therapy without side effects could improve dramatically chemotherapy
7. High EGFR expression a predictor for improved survival with cetuximab plus chemotherapy
8. EURTAC Phase III study: Erlotinib nearly doubles progression-free survival vs. chemotherapy
9. Innovative UBC-BC Cancer Agency system reduces waitlisting for chemotherapy patients
10. Tai chi could be key to overcoming cognitive effects of chemotherapy
11. Hormone test predicts ovarian function after chemotherapy for breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2015)... 2015 Wixom, Michigan: Proof. Pest Control, a family-owned ... a new twist to its robust line of services-a ... used for general pest management. , “We like ... Wixom Branch Manager. “The average person cringes when they see ... with problems that most people don’t even want to think ...
(Date:5/30/2015)... the Snail ” was featured on NewsWatch as part of ... and coolest applications on the market for iOS, Android, and ... conducted the app review and shared with viewers how this ... Interactive mobile games for children have become quite popular these ... playing are doing much for their intellectual development. However, there’s ...
(Date:5/29/2015)... 30, 2015 “In the current ... and federal regulations, we provide education that will ... who are suffering from pain, within the boundaries ... MD, professor of rehabilitation medicine and President/Medical Director ... Park, Kansas. , A new flight of PAINWeekEnd ...
(Date:5/29/2015)... May 29, 2015 M3 USA MDLinx.com, ... in 14 medical specialties, now offers The Smartest ... spectrum of rheumatology disorders ranging from Fibromyalgia and Osteoporosis, ... editorial director of MDLinx, and Caroline Tredway, editorial head ... impact it will have on the physicians who participate. ...
(Date:5/29/2015)... Angeles, CA (PRWEB) May 29, 2015 The ... greatly in the last decade. New and more efficient methods ... hair available to balding patients. One of the most cutting ... Parsa Mohebi Hair Restoration is the technique of extracting hair ... to scalp transplants are performed to correct male pattern ...
Breaking Medicine News(10 mins):Health News:Proof. Pest Control-Now Offering 100% Organic Pest Control in Southeast Michigan 2Health News:An Aesthetic Game that Engages and Educates Children was Featured on NewsWatch Television 2Health News:PAINWeekEnd Kansas City: Pain Management CME for the Main Street Practitioner 2Health News:MDLinx Launches Smartest Rheumatologist 2Health News:Beard to Scalp Hair Transplant: Newest Advance in Hair Transplant Technology 2
... , , PISCATAWAY, N.J., Aug. 10 ... today announced its second quarter financial results for the three and six months ended ... Three Months Ended June 30, 2009 with Three Months Ended June 30, 2008: ... to $2.04 million, up 32% from $1.55 million. , ...
... , PRINCETON, N.J., Aug. 10 Pharmasset, Inc. (Nasdaq: ... discovering, developing, and commercializing novel drugs to treat viral infections, today ... June 30, 2009. , , Financial ... during the quarter ended June 30, 2009 compared to $0.5 million ...
... SALT LAKE CITY, Aug. 10 ("WorldHeart", Nasdaq: WHRT ... today that it has appointed Morgan Brown as Executive Vice President ... experience to WorldHeart. , , Mr. Brown ... Officer and Senior Vice President since 2008. While at Lifetree Clinical ...
... SHENZHEN, China, Aug. 10 /PRNewswire-Asia-FirstCall/ -- Mindray Medical,International ... of medical devices worldwide announced today its selected unaudited,financial results for ... , Highlights for Second Quarter and First Half ... $160.1 million, an increase of, ...
... NASHVILLE, Tenn., Aug. 10 Healthcare Realty Trust Incorporated (NYSE: ... for the quarter ended June 30, 2009. This dividend, in ... 2009 to shareholders of record on August 21, 2009. , ... investment trust that integrates owning, managing and developing income-producing real estate ...
... WESTPORT, Conn., Aug. 10 FoodBizDaily.com, the leading news source for ... "International Trade Opportunity: The Brazilian Acai Berry." , , ... firm for the natural products industry, Americans spent more than $108 ... up from just over U.S.$62 million the year before. , ...
Cached Medicine News:Health News:Milestone Scientific Reports 44% Increase in Revenues in First Six Months of 2009 Compared to Prior Year 2Health News:Milestone Scientific Reports 44% Increase in Revenues in First Six Months of 2009 Compared to Prior Year 3Health News:Milestone Scientific Reports 44% Increase in Revenues in First Six Months of 2009 Compared to Prior Year 4Health News:Milestone Scientific Reports 44% Increase in Revenues in First Six Months of 2009 Compared to Prior Year 5Health News:Milestone Scientific Reports 44% Increase in Revenues in First Six Months of 2009 Compared to Prior Year 6Health News:Milestone Scientific Reports 44% Increase in Revenues in First Six Months of 2009 Compared to Prior Year 7Health News:Milestone Scientific Reports 44% Increase in Revenues in First Six Months of 2009 Compared to Prior Year 8Health News:Pharmasset Reports Fiscal Third Quarter 2009 Financial Results 2Health News:Pharmasset Reports Fiscal Third Quarter 2009 Financial Results 3Health News:Pharmasset Reports Fiscal Third Quarter 2009 Financial Results 4Health News:Pharmasset Reports Fiscal Third Quarter 2009 Financial Results 5Health News:Pharmasset Reports Fiscal Third Quarter 2009 Financial Results 6Health News:Pharmasset Reports Fiscal Third Quarter 2009 Financial Results 7Health News:Pharmasset Reports Fiscal Third Quarter 2009 Financial Results 8Health News:WorldHeart Appoints Morgan Brown as New Vice President of Finance and Chief Financial Officer 2Health News:Mindray Announces Second Quarter 2009 Financial Results 2Health News:Mindray Announces Second Quarter 2009 Financial Results 3Health News:Mindray Announces Second Quarter 2009 Financial Results 4Health News:Mindray Announces Second Quarter 2009 Financial Results 5Health News:Mindray Announces Second Quarter 2009 Financial Results 6Health News:Mindray Announces Second Quarter 2009 Financial Results 7Health News:Mindray Announces Second Quarter 2009 Financial Results 8Health News:Mindray Announces Second Quarter 2009 Financial Results 9Health News:Mindray Announces Second Quarter 2009 Financial Results 10Health News:Mindray Announces Second Quarter 2009 Financial Results 11Health News:Mindray Announces Second Quarter 2009 Financial Results 12Health News:Mindray Announces Second Quarter 2009 Financial Results 13Health News:Mindray Announces Second Quarter 2009 Financial Results 14Health News:Mindray Announces Second Quarter 2009 Financial Results 15Health News:Mindray Announces Second Quarter 2009 Financial Results 16Health News:Mindray Announces Second Quarter 2009 Financial Results 17Health News:Mindray Announces Second Quarter 2009 Financial Results 18Health News:FoodBizDaily.com Announces New Free Report - 'International Trade Opportunity: The Brazilian Acai Berry' 2
(Date:5/29/2015)...  Epic Sciences announced today that the company will ... resistant prostate cancer patients, at the 2015 annual ... This application expands the investigational utility of Epic ... to characterize circulating tumor cell (CTC) genomic alterations. ... heterogeneous clonal CTC populations harboring separate genetic alterations. ...
(Date:5/28/2015)... Lilly and Company (NYSE: LLY ) announced today the ... up to $1.6 billion aggregate principal amount of certain of ... tendered, and did not validly withdraw, their notes on or ... time, on May 27, 2015 (the early tender date), and ... receive the total consideration. The total consideration for each series ...
(Date:5/28/2015)... May 28, 2015  Maetrics ( http://maetrics.com ), a ... sector, wrapped up a successful conference, "The cost of ... industry," today in Zurich . ... and its Switzerland -based team, experts ... Medical Technology field to an exclusive local audience. The ...
Breaking Medicine Technology:Genetic Analysis of Single Circulating Tumor Cells Shows High Intra-patient Heterogeneity 2Genetic Analysis of Single Circulating Tumor Cells Shows High Intra-patient Heterogeneity 3Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 2Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 3Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 4Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 5Maetrics Hosts Innovative Medical Cluster Event in Switzerland 2
These units, though small, still offer sufficient output to ensure current is fully adjustable from 0 to 70 mA. Instruction manual, ball electrodes, battery and leads with alligator clips are include...
... of flexible lighting products. The first is ... different sizes 5", 10", and 15" (refers ... light). These lights are for use in ... ,The second group of flexible lights is ...
These units, though small, still offer sufficient output to ensure current is fully adjustable from 0 to 70 mA. Instruction manual, ball electrodes, battery and leads with alligator clips are include...
Designed to be used for neuromuscular blockage monitoring. Provides for easy placement over the ulnar nerve on a patient's wrist. Dual element permits non-invasive monitoring using a single electrode...
Medicine Products: